Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.42
0.00 (0.00%)
At close: May 19, 2026, 4:00 PM EDT
13.41
-0.01 (-0.07%)
After-hours: May 19, 2026, 7:10 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.52 billion as of May 19, 2026. Its market cap has increased by 41.36% in one year.
Market Cap
3.52B
Enterprise Value
10.98B
1-Year Change
41.36%
Ranking
Category
Stock Price
$13.42
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.52B, a decrease of -58.13%. That is a compound annual growth rate of -15.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 3.52B | 89.05% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck & Co. | 275.09B |
| Novo Nordisk | 207.87B |
| Amgen | 176.11B |
| Gilead Sciences | 160.88B |
| Pfizer | 144.37B |
| Bristol-Myers Squibb Company | 116.40B |
| Sanofi | 103.16B |
| GSK plc | 99.05B |